We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App





Seegene Showcases New STARlet-AIOS All-in-One Solution for All Molecular Testing at MEDLAB Middle East

By LabMedica International staff writers
Posted on 25 Jan 2022
Print article
Image: STARlet-AIOS (Photo courtesy of Seegene, Inc.)
Image: STARlet-AIOS (Photo courtesy of Seegene, Inc.)

Seegene, Inc. (Seoul, Korea) presented its recently launched STARlet-AIOS All-in-One Solution for All Molecular Testing at MEDLAB Middle East which took place 24-27 January 2022 at the Dubai World Trade Centre.

Seegene’s new STARlet-AIOS is a unique modular configuration that integrates existing standalone instruments, enabling easy installation, upgrade and maintenance. Combined with Seegene's proprietary high-multiplex real-time PCR reagent technology, Seegene STARlet-AIOS provides an ultimate solution that could perform various syndromic tests with one system. The STARlet-AIOS is the world's one and only modular concept that enables a fully automated workflow while maintaining the standalone instruments, STARlet and CFX96 Dx. It no longer requires a large installation space and provides convenience in maintenance and repair.

What sets Seegene STARlet-AIOS apart is its unique high multiplex Real-Time PCR reagent technology. Within the same disease group such as respiratory, GI, or STI, Seegene’s syndromic test can find the exact cause of a specific symptom with a single test. Seegene’s currently available products can be applied on the STARlet-AIOS and its newly developed products will also be compatible with the solution, thus further increasing its expandability. With the all-in-one solution, diverse syndromic tests can be carried out with a single system, optimizing the testing environment.

From sample input to data analysis, Seegene STARlet-AIOS provides a streamlined process for molecular testing. The entire workflow is fully automated with Seegene’s solution. Just a click of a button is all that is needed. An inserted sample plate goes through the extraction, followed by the PCR setup process within the extraction instrument STARlet. Once the extraction and PCR setup are finished, the sample plate is moved down to the lower level by the elevator robot. The plate is then picked up by the plate handler robot and moved to the plate sealer for automated sealing process. Once the sealing is done, the plate is again picked up by the plate handler robot and put into the CFX96 for Real-Time PCR. After the PCR, Seegene’s seamless software solution provides not only accurate quantitative test results but also customized statistical analysis in an easy to see visualized format with insights.

By completely eliminating the manual process, the possibility of human error and contamination is minimized throughout the entire testing process. As a result, the medical staff can obtain accurate test results by working in a safe and efficient environment. Seegene STARlet-AIOS is a compact yet complete testing solution that generates same-day results even with small sample sizes, making it perfect for clinics and labs of all sizes.

Related Links:
Seegene, Inc. 

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.